Citation Impact
Citing Papers
Systemic Delivery of Microencapsulated 3-Bromopyruvate for the Therapy of Pancreatic Cancer
2014 StandoutNobel
Polycation-siRNA nanoparticles can disassemble at the kidney glomerular basement membrane
2012
Systemic Targeting of CpG-ODN to the Tumor Microenvironment with Anti–neu-CpG Hybrid Molecule and T Regulatory Cell Depletion Induces Memory Responses in BALB-neuT Tolerant Mice
2008 StandoutNobel
Pharmacokinetic Properties of 2′-O-(2-Methoxyethyl)-Modified Oligonucleotide Analogs in Rats
2001
Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas
1988 StandoutNature
TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity
2007 StandoutNobel
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
2013 Standout
Nanomedicine and drug delivery strategies for treatment of inflammatory bowel disease
2015
De novo protein design. I. in search of stability and specificity
1999 StandoutNobel
The emerging role of lncRNAs in cancer
2015 Standout
Defensins: antimicrobial peptides of innate immunity
2003 Standout
Programmable RNA Tracking in Live Cells with CRISPR/Cas9
2016 StandoutNobel
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Nanoparticles in cancer therapy and diagnosis
2002 Standout
Delivery materials for siRNA therapeutics
2013 Standout
Neuroblastoma: biological insights into a clinical enigma
2003 Standout
Modification of splicing in the dystrophin gene in cultured Mdx muscle cells by antisense oligoribonucleotides
1998
Multinuclear Non‐Heme Iron Complexes for Double‐Strand DNA Cleavage
2009 StandoutNobel
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
2011 Standout
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
Antisense oligonucleotides: towards clinical trials
1996
Non-viral vectors for gene-based therapy
2014 Standout
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
2015 Standout
A new liposomal formulation for antisense oligodeoxynucleotides with small size, high incorporation efficiency and good stability
2000
Mind the gap: A survey of how cancer drug carriers are susceptible to the gap between research and practice
2013
Human Splicing Finder: an online bioinformatics tool to predict splicing signals
2009 Standout
The use of synthetic polymers for delivery of therapeutic antisense oligodeoxynucleotides
2002
Targeting RAS signalling pathways in cancer therapy
2003 Standout
Establishment of human squamous carcinoma cell lines highly and minimally sensitive to bleomycin and analysis of factors involved in the sensitivity
1992
The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses
2004 Standout
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
2017 Standout
Antisense oligonucleotides as therapeutic agents
1999
Normal Functional Capacity in Circulating Myeloid and Plasmacytoid Dendritic Cells in Patients with Chronic Hepatitis C
2005 StandoutNobel
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
2012 Standout
Death and anti-death: tumour resistance to apoptosis
2002 Standout
Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis
2004 Standout
Idiopathic Pulmonary Fibrosis
2001 Standout
Revealing the world of RNA interference
2004 StandoutNatureNobel
Double blind, placebo controlled trial of the remission inducing and steroid sparing properties of an ICAM-1 antisense oligodeoxynucleotide, alicaforsen (ISIS 2302), in active steroid dependent Crohn's disease
2002
Antisense Pharmacodynamics: Critical Issues in the Transport and Delivery of Antisense Oligonucleotides
1999
Liposomal drug delivery systems: From concept to clinical applications
2012 Standout
Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: formation of novel small multilamellar vesicle structures
2001
Double strand DNA cleavage with a binuclear iron complex
2006 StandoutNobel
Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase
1996
Pathogen Recognition and Innate Immunity
2006 Standout
DLS and zeta potential – What they are and what they are not?
2016 Standout
Targeted Delivery Systems for Oligonucleotide Therapeutics
2009
Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer
1985 Nature
Geometric and Electronic Structure/Function Correlations in Non-Heme Iron Enzymes
1999 Standout
Efficient DNA Cleavage with an Iron Complex without Added Reductant
2000 StandoutNobel
Effects of Pirfenidone on Procollagen Gene Expression at the Transcriptional Level in Bleomycin Hamster Model of Lung Fibrosis
1999
RNA Targeting Therapeutics: Molecular Mechanisms of Antisense Oligonucleotides as a Therapeutic Platform
2010
Cleavage of Nucleic Acids by Bleomycin
1998
Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis
2004 Standout
Water as an Active Constituent in Cell Biology
2007 Standout
Antitumor Antibiotics: Bleomycin, Enediynes, and Mitomycin
2005 Standout
Characterization of Cationic Liposome Formulations Designed to Exhibit Extended Plasma Residence Times and Tumor Vasculature Targeting Properties
2010
Max: A Helix-Loop-Helix Zipper Protein That Forms a Sequence-Specific DNA-Binding Complex with Myc
1991 StandoutScience
Possible Mechanisms of Bleomycin-Induced Fibrosis
1990
Ligand Exchange and Spin State Equilibria of FeII(N4Py) and Related Complexes in Aqueous Media
2011 StandoutNobel
Progress in the Delivery of Therapeutic Oligonucleotides: Organ/Cellular Distribution and Targeted Delivery of OligonucleotidesIn Vivo
2003
Oxidative Nucleobase Modifications Leading to Strand Scission
1998 Standout
Rapid phosphorylation of the L-myc protein induced by phorbol ester tumor promoters and serum.
1989
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Biodegradable polymers as biomaterials
2007 Standout
CpG Motifs in Bacterial DNA and Their Immune Effects
2002 Standout
Cell and Environment Interactions in Tumor Microregions: The Multicell Spheroid Model
1988 StandoutScience
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Growth Factors and Cancer
1991 StandoutScience
Two prohormones for gastrin-releasing peptide are encoded by two mRNAs differing by 19 nucleotides.
1986
Analysis of Noncovalent Complexes of DNA and RNA by Mass Spectrometry
2001
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Immunotoxins for targeted cancer therapy
1998
Phase I Clinical and Pharmacokinetic Study of Bcl-2 Antisense Oligonucleotide Therapy in Patients With Non-Hodgkin’s Lymphoma
2000
Integrating Genetic Approaches into the Discovery of Anticancer Drugs
1997 StandoutScienceNobel
A family of unusually spliced biologically active transcripts encoded by a Drosophila clock gene
1987 StandoutNatureNobel
Targeted Drug Delivery with Polymers and Magnetic Nanoparticles: Covalent and Noncovalent Approaches, Release Control, and Clinical Studies
2016
Cyclodextrin-Containing Polymers: Versatile Platforms of Drug Delivery Materials
2012
The corticostatic (anti-ACTH) and cytotoxic activity of peptides isolated from fetal, adult and tumor-bearing lung
1987
Atomically Precise Clusters of Noble Metals: Emerging Link between Atoms and Nanoparticles
2017 Standout
Ameliorating effect of murine interferon gamma on bleomycin-induced lung collagen fibrosis in mice
1986
Phosphoinositide 3-kinase γ plays a critical role in bleomycin-induced pulmonary inflammation and fibrosis in mice
2010
Works of J E Zuckerman being referenced
Evaluation of antifibrotic drugs in bleomycin-induced pulmonary fibrosis in hamsters.
1980
Pharmacokinetic properties of several novel oligonucleotide analogs in mice.
1996
Systemic delivery of siRNA via targeted nanoparticles in patients with cancer: Results from a first-in-class phase I clinical trial.
2010
A gelonin-containing immunotoxin directed against human breast carcinoma.
1992
Pharmacokinetics in mice of a [3H]-labeled phosphorothioate oligonucleotide formulated in the presence and absence of a cationic lipid
1996
Phase I Safety and Pharmacokinetic Profile of an Intercellular Adhesion Molecule-1 Antisense Oligodeoxynucleotide (ISIS 2302)
1997
In vitro selection and characterization of a bleomycin-resistant subline of B16 melanoma.
1986
Biochemical and structural alterations of hamster lungs in response to intratracheal administration of bleomycin
1980
Gastrin releasing peptide is a selective mitogen for small cell lung carcinoma in vitro.
1985